XPN-52950-12261
2 vaccinations
1 coded response
9 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 371 / TN
- Registered
- 2020-12-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2020-12-27
Registered in v-safe
- 2020-12-28
- 2021-01-04
-
2021-01-11
Dose 2 — Pfizer-BioNTech
- 2021-01-18
- 2021-01-25
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-22
-
2021-04-12
Survey response — 3 months, dose 2MedDRA: Stillbirth — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Stillbirth at 24 weeksMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-12 | Unsuccessful |
Free text
Release 7 — 3 months, dose 2
Symptoms: Stillbirth at 24 weeks
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Stillbirth | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release